Jeffrey Ellis

Jeffrey Ellis is a seasoned professional in program management and financial planning with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Senior Director of Program Management at Dyne Therapeutics since December 2022, Jeffrey previously held the position of Director of Program Management at BlueRock Therapeutics from June 2021 to December 2022. Prior experience includes a range of roles at Alnylam Pharmaceuticals from June 2012 to June 2021, culminating as Senior Manager of US Marketing and incorporating responsibilities in forecasting and analytics, business planning, and analysis. Earlier in the career, Jeffrey worked as a Financial Analyst at EMD Millipore. Academic qualifications include a Master of Business Administration from Boston University and a Bachelor of Business Administration in Finance and Economics from the Isenberg School of Management at UMass Amherst.